CD4 and glioblastoma: Furthermore, in a recent glioblastoma (GBM) study, Wang et al. found that the maintenance of CD4+ CAR T cells correlated positively with the recursive killing ability of CAR T cell products derived from GBM patients (so-called “serial killers [8]”).